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~ 1  How to Reduce Costs While Preeerving 
" Olagnoltle Accuracy Among Patlenti Presenting 
to the Emergenw Oepartment W~lh Ch~t Pain 
M,G, Sctammamlla, C,L Wolfe, P Lizofto, M,W. Dae, B. Sirke, E.H Ootvin~ck 
Un~ve~'y ot Cat#emma, San Fr~ncmco. San Fmnc~sc~ CA, USA 
To ¢let~nm~ lhe safely and o0st-efft~'livenetm ofinpatient w,  outpatient eval, 
uallo~ el ~u l~ with chest pain and nondmgno~tic ECG, we ¢omparnd 
o~t~rn~ and co~ts in 57 consecuIiw IP~tienls (pts) pmseflting to the Em~p 
g(mo/Depa!Ime~! (ED) with chest pain who were N3't11111~:~ to hO~Oi~l vemt~ 
wod~.up in EO, R~tt (R) MIBI was paftofmed in ~115.7, Th~ inllml 34 pts w~.m 
sh~ied alter he~Pital ~ld~salo~ for ~le-,Out ML R MIBI Wl~ ro~l  in 27 pt~. 
Stm~ (St MIBI done 48 hnom later in 8 of these pts was abnormal in 2, floqwr* 
ing coronary a~iogrephy (CA) and PTCA Them were nO isChem~ events 
r, ofed o~ follow-up (m~t  9 mo~). R MIBI was ~m~!  m 7 p~ and brought 
CA in 4. PTCA in 2, ~ a~tet l  me~ lherapy in 3. The Cost of inpatlem 
evalualmn was $3,0934~. The ne)1 ~ consecutive pts were evaluated in the 
ED, R MIB! waa al~n, onnal in I Pt ~ AMI. R MIBI scan was normal in 2~ 
pat~ms S MIBI wa~ ~ m 12 ot these pts Ihe sarr~ dap/, aed was ab- 
nom~l in I Pt mquinng CA and CABG. t t pts ~ noemal R had norma! eany 
S, M!el and were d~scha~ged toe OUtpallen! folk)w-up. No mchem~ events were 
noted on lollow-up of pts w~th nom~ R and S MIBI (mean 1 me}. The cost 
OI 0ut/mpatmnt evaluation of ~ group was ~,553/pt. The COst Of evaluating 
the 11 pts wilh nom~al R and S MIBland fo~owed as out~ was $ 2.009J~. 
Conc/us~on. Normal EO R MIBI followed by aPll~OPr~le S MIBI excluded 
acute ~K~al  isclxm~a nd ~lenMied pls at risk w~th CAD. ~h~s outpa~nt 
approach to evaluation of ED patients ~ chest pare of uncertain e~ology m 
safe and h~oJmy ccst-eftectwe 
Extent With T¢,-~Jm Te~hrofosmin SPECT 
I~ ing?  
MR. Mansoor, A.W. Al~berg, M.G Leone, C.C. McGilI. G.M. Cyr, A Rt.,sseIl. 
DM Cross. D Waters, GV Hefler Har1~dHos~atancttheUnn~ersttyet 
C ~ .  Hartford CT USA 
To evaluate the effect of the vased~lator stres~ agent upon de~c't s~ze, 30 
pat~mts with known corena~" artery disease Lmderwent rest, adenasme (AD 
0.84 mojkg over 6 minutes) and dipyndamofe (DiP 0.56 moJkg over 4 min- 
utes) sh'ess testing with Tc-99m tetrofosmin (25-30 mCl| SPECT iroaojng on 
separate days..~Jt re;ages were ',r~terpreted by 3 nuctea~ cardiologists w~,out 
knowledge of pa~t  ~ent~ty o~ 5he~ I~Otocol u~ng a 17 segment model 
wn~ each segment scored from 0 : non~al to 4 = absent photon counts. The 
number of non'T~al. ~ ,  and reversible segn~nts was determined as 
was a summed stress, rest and rever~bdlty score. 
Nt.rm~LW or Segments SumrmeO Detecl Seines 
Norm A~no~'rn Rea~f~ stte-5~ re51 rever~ 
AD 278 232 102 139~94 75t94  63 :37  
D~P 315 195 "3 121 ~92 71 '~ Sl~, 5~ ~ ~t 
p 0003 0003 003 0005 NS 004 
ResufLs: Adenosine infusion resulted in sigmficantly greater stress and 
reversibdity scores as well as a larger number of abnormal and reversible seg- 
ments than chpyndamo(e. More completely reversible defects were identified 
w~th adenosine 
ConclusK?n: Adenostno with Tc-99m tetrotosmm SPECT imaging m I:~tter 
than dipyndamole at identifying the presence and extent of detects in the 
same pabents with corenaW atlery disease. 
l 1129-166 [ Quant i tat ive  Tc-99m Tetmfosmin  SPECT Imaging 
in the  Assessment  o f  Coronary  Ar tery  Disease 
W.S. Hwang, Z.-X. He. G.A Reyes, E. Cwajg ~ .M.S. Verani. Baytor College 
of Medicine. Houston. TX, USA: ~ Sponsored by CAPES. Brazd 
Tc-99m labeled tetrefosmin scintigraphy has been shown to be useful for the 
detection of coronary artery disease (CAD). Data are, however, scanty on 
the accuracy of quantitative stress Tc-99m tetrofosmin singte photon emis- 
sion computed tomography (SPECT) imaging Accordingly, we studied 107 
patients. 75% males, mean age 60 ± 11 years, who underwent quantitatwe 
stress (treadmill [n = 49], adenosine In = 27]. dobutamine [n = 7]) Tc-g9m 
tetrofosmin SPECT imaging. Eighty-three patlan;3 had angiography within 3 
months of the SPECT study (average time interval 15 ± 21 days) and 24 
patients had a low likelihood for CAD. Coronary angiograms were road by an 
independent, blinded experienced angiographer. 
Tomograms were quantified using polar maps compared to tracer and 
stros,~-specific normal data banks. Defects involving >3% of the left ventricle 
were cor3idered abnormal. Overall sensitivity, specificity and predictive ac- 
curacy of quantitative stress Tc-99m tetrofosmin SPECT were 84% (62/74), 
44% (4/9) and 80% (66/~',), with a nonmalcy rote of 88% (21/24} Tt~e mean 
dolt,tit size in patients with abnormal corona~ ang,Ogmm~ involvec! 26 ~, 15% 
of the left ventncto, The 0v~ratl sens=twlty, sl~cffK:lty anO I:~edct!ve accu 
racy for 0~t(~'llon of all ~nosod ¢Or~naty afterms weru b t % (;6/14~), ?8% 
(78/100) and 78% (~) ,  ml~X~lvely, SensffMly for the ~ of mad 
stl}nosea (50--74%) was signifk~lmthj lower th~n for severn ( .- 7,5%) 
20% (7/34) v~ 60% (69/115). p .- 0.0001 in co~; l~n,  quantrlati~ Stres~ 
Tc-99m totrof0em!n SPECT mnagmg provides nigh INmlutivfiy ~ ~ n~,, 
m~lcy rate for deleting and kc~lizing s~vem CAD 
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~anselophagell Echoc411Rtlognlphy and 
oagulldion IndlcMom In I~nm 
Nonvalvulllr Atrial Fibrillation: A I~Ipl~'lh~ 
3-Yem Study 
C. PandulloL C Glan~ante, N. FJo~, S. Calabrese, R. La Verde, 
C. Mazz0ne ~ ,S. ScadiL G. Guammn tnst#uteotCtin~calMeo~ne, 
UnNen~ty 01Tnes~ ~raly: ' Caro~ovascutar Centre, naty: EmeFgency Un~ 
Ospeda/e Maggo~ Tnaste, Ifa/y 
Ba~ground:Bofhleft a rial appendage spontaneous echo contrast and thrum- 
bus am aseoc~ated wnh malor risk of thremboembolism in patien~ with ~Dn- 
v~,rolar atrial fibnffation. ~ r ,  the4r coagulation determinants m patmnts 
have not been lulty eluc~dat~ 7gtr,~emmre, the pre(~ct~ value. * coagula- 
tmn indicators has not been yet explored =n term of tr0mboemb~. ,verff~ 
~ s :  =) to ven~ wh~ther nonvak, utar atnal hbn l l~  ~s ssooaleo 
,=;~h abnormal:hes of fibnnoqen, Dd~,ner and f ibnno~ A pla..ma levels 
and. it so. whether a relal~'~shlp l~ween these ~oaQulal~on i d~lom and 
echoc 'a rd~ data exists; ii) ~0 Verify whether echocardlo~r'd~3h~c data, 
D-d~mer or Rbnnopapltde A can be pred~lom of hombeembolm events. 
Met'nods: We delern~ned fibrmogen, D-dm~r and fibnnopepl~e A in 77 
consecutive pa~ents with norwahmlar atna~ ld0nllat~n who were unOergomg 
transesophageal echocardmgrabhy and m 117 matched controls. Patients 
were tollowe~ up for a 3-year penoO 
Result: A left alnal appendage thro~ in 27 patients (35%), a sponta- 
neous echo contrast alone in 14 (18%) were found. Fibnnogen, D-dimer and 
F PA were S~nlficantly higher in Study populatmn than in contr~ group (Fib- 
nnogen 335 ~ 106 vs. 2B3 ~ 71 mg/dl p ~ 005; D-dimer 436 t 271 vs 306 
; 271 noJm| p - 001: FPA 86 • 62 v5 20 ~ 04 ng.~ml p ~ O001), Patients 
w~th left atrml appendage thrombus had h~gher F P A plasma levels. 
Thromboeml3ohc events; patients w~th a lower atnal appendage flow profile 
have a relative risk of 2.0: patmnts within the upper fertile of F.P.A vel~es have 
a relatrve risk of 8.2 times. 
Conc/u,,3mns Abnormal plasma levels of tibnnogen, D<llmer and F P.A 
indicate that the coagulation system ,s actnrated in patients withn onvalvular 
amal fibnllation. F.P.A plasma levels are s~gnificantiy higher m patmnts with left 
atnal apl~ndage thrOmbus than in the other groups. F.PA is the most efficient 
pred~or of the clmical outcome after 3-year fol/ow-up. 
~ Thrombomodulin Expression on Atrial 
Endocardium in Patients With Atrial Rbrlllation 
T. Kuretobi, Y. KoreLsunel. H. Sate, H. Sate, Y. OhnishL T. Kuzuya, M Hen. 
H. Matsuda. Osaka Um~rsffy. Osaka Hos~fall. Suita. Japan 
Backgreun~. Thrombornoduhn CrM), a potent anticoagulant factor, iS localized 
on the surface of endothehal and endocordial cells and It ~s reportnd that 
the expression of TM is modified by vascular flow pattern Therefore, we 
hypothetize~ that the expression of TM on atnal endocardium may also be 
modified !n atrial fibrillation (AFt patientS. 
Methods: 20 patients (mean age: 60.5. 7 AF and 13 non AFt underwent 
open heart surgery were enrolled ~n this study. The nght atnal appendage 
was sampled just before inser~ng cannula into nght atnum to Start exlraco~- 
poneal circuta'non. "iM expression on the atnal endocer0ium was evaluated 
by immunohistochemical method, and the grade of its staining was scored. 
Moderate Weak 
Staining unrfonn patchy unil0rm palchy 
AF (n = 7) 0 1 0 6 
Non-AF (n = 13) 2 5 3 3 
ResufLs: The level of TM staining was markedly lower in AF than non 
AF patients. However. the extent ~}f ibrosis in atnal myocardium was net 
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significantly different between the groups (AF FJ,3 + 3,9 vs non-AF 6,2 ~: 3,4% 
N,8,), 
Conclusion: We concluded that the reduced TM expression on atrial endo- 
cardlum may also contribute to the atrial thrombus formation In patients with 
AF, 
• Endothellnl and PlMelet Activation In Oysfunctlon 
PMlent Wlth Chronl¢ Atrlsl Flbrlllatlon' 
Interactlons Lesdlng to l"hmmhogenuls? 
F, U.Sew.Hee, A,D, Blann, G,Y,H. Lip, Haemosfasls, Thrombosis and 
V~¢'ul~r elolow Urtlt, Unlvemtly D~pl. of Medicine, Th~ City Hrmplfal, 
Btrmlngt~m, Bf8 ~;tH, Unlt~f Kingdom 
Bad~urM: Atrlffl flbflllation II II ~mmon anlhymle whteh le asso01otod with 
Stroke endthmmbcomboUsm, Recent studied have suggested that eiffel fibril, 
lotion oonltm A hypemosgulobte late, However, the thrambotle tendaney el 
blood Is lnfluen0ed by many foctom Including Interaotlon= between endothelial 
cells end pllIolets, 
M~thed~" We pedolmod a oross,seotinnol study ol Indices el platelot and 
endothelial cell kln~tlon In 4~ potlents (31 msleo, mean age ,* 71) with 0hrenlo 
eiffel fibrillation end eompamd them with 4f! Age, and sac,matched ~on, 
tmlll, We meosumd the platalat aotlvstlon marker soluble P-seteotln (e,Poel) 
(ng/tnL) trod endethetl~l markem soluble thrembomodutln (aTM) (nglmL) end 
son Wlllebrand factor (vWF) (IU/dL) by ELISA mP, thods~ 
~u~:  
P~tmnl~l 133 ~1 24 I~5 (lSQ-~9~,) ~4 -1~ 18 
Control 104 .~ ~ ~0~ (ELF-,1901 40 ~: tO 
P vlI~s ,~ 0.01 0,48 4,05 
Conc/u,Won: This study suggests the presence ol endothelial dysfunction in 
pstten~ with atrial fibrillation, as indicated by significant elevation el van WIIle. 
brand fe0for lavela, although the elsvMIon In soluble thrombomedulin was 
only of borderline significance. There was no significant tncreece In soluble 
P,lele¢~ln, although previous studies have Indicated high ptalelet activation 
in this condition, Further ~tudle~ exploring the intoraotlon between platelets 
end the endethallum are needed, a~ the presence oi endothallal dysfunction in 
atrial fibrillation may contribute to the high risk o1 stroke and thrembcembollsm 
In this condition, 
~ L e f t  Ventrlcular Smoke: An Echocardlographlc 
Study 
L, Baruch, P, O'Dwyer, X. Fann, P. Patacsil, S. Guerm, Division of Cam/iology 
Bronx VA Meclical Center, Cardiovascular InsMuh~, Mr. Sinai Hospital, NY, 
NY, USA 
Smoke IS commonly seen during TEE In the left atrium of pts with AFib (severe 
atrial dysfu~tlon) snd Is associated with thremboembellsm The Inclder¢'e 
and correlates of LV smoke are unknown, Embollo events am common In pts 
with congestive heart failure with an annual Incidence of 2-3%, Transthoraclc 
ochocardtography (TTE) using 2-3,5 MHz transducers rarely permits visual. 
Izatton of LV smoke. Higher frequency transducers may permit visualization 
of LV smoke, We evaluated the ability el a high frequency 5 MHz transducer to 
detect LV smoke in 710 consecutive pts who unde~vent TTE, We compared 
the 58 pts with smoke (SEC+) to the 652 pts without smoke (SEC-) with re- 
spect to LV systolic function, 1 ) ejection fraction (El =) and LV diastolic function 
2) tmnsmltrat E/A ratio 3) deceleration time (mace) (DT), 4) pulmonap/vein 
systolic/diastolic ratio (S/D), 4) LV dlastollo dimensions (cm) (LVID), and the 
i~tdence of thrombl. 58 pts (8%) had LV smoke. 
Age EF% LVID (cm'l DT (msec) Thmrnbt 
SEC.¢. 636 37.8 5.6 178.3 34% 
9EC - 61 O 559 50 217.3 0 
p <O001 <0001 0.003 0.004 0.2 
Pts with smoke have greater systolic and diastolic dysfunction as mani- 
fested by lower election fractions, larger internal diameters, greater EIA and 
lower S/D than those without smoke, No significant difference in the incidence 
of thrembl '.vas noted, 
Conclusion: The clinical significance el LV smoke, its association with 
embolic events (as In AFih), and the potential benefit of anticoagulants Jn pts 
with CHF and LV smoke needs to be determined. 
• Trsnsssophsgul E¢hocerdlogrsphy Considerably 
Impacts the Management of Petlsnte With Stroke, 
Transient lachemlc Attack or  Peripheral Embol ism 
A,M,A, Hasnle, M.F, Stodderd. N. Calzada, R,A, Longeker, University of 
Louisville, LoulsWlle, KY, USA 
of pts with potential emb~ lie events, such as non, hamorraghlo stroke (CVA), 
transient leahamlo eftaok ~IA) or peripheral embolism is contmvemlel, 
Mefttco~: Thus, 155 o0nseoutlve pie (mean ego 6t ~ 14 ym: t02 
F) undergoing TEE for w~rk.up of CVA (n - 90) TIA (n - 37) er PE (n ~, 28) 
were enrolled, Medical ©harts were reviewed to dotermll~ the Influen~-~ of 
TEE msultl on treatment end further In.hospital work-up, TEE wu amx~,mtd 
for the presence el intmcerdloo thmmbus, spontaneous eehe contmM ($EG), 
septlll deleet, loll,sided v;getotlon, aertio plaqge (~5 mm or m~to), ~tqmt 
foreman ovule (grade ,. 2) end valvular flbdn etmn~, 
Roast:TEE was dlegnoatio f e potential emballo souse in S'/% (n = 89) 
of the entire study population a~l In 58% (n =, 52) ul ,i~ CVA, 57% (n = ~t) 
of the TIA end 51% (n ,~ 16) oi the PE group (p = ns), TEE multlz changed 
medloetion (n =J 44) ot suRiiolll (n ,, 1) treatment in ~Ig% (n ,~ 45) and altered 
planned dlognolttio studies In 15% (n = 24) el patients, Ant~agulation with 
warladn Wall alerted in 14% (n =~ 21 ) on lhe basis of TEElindinge ol intmcardla¢ 
thrombus (n = 17), dense left atH= SEC (o ,, 2), widely patenl foremen ovale 
membrane (n = 1) or numemue fib~n Strands (n ~ 1 ), Asl~rin was sladN~l m 
(n = 14) for fibrin strands, In 5% (n = 7) antibiOtl~ were started on the basis el 
TEE findings el tell,sided vegetation and subsequent positive blood cuffum 
(n ,~ 5), Them were no signitioent diltomp¢es in tha change in treatment o~ 
work.up among the stroke, transient isct~mie agack or perild~erel mb~tsm 
greu~s, In 71P,~ (112/155) el pt~, TEE hndlngs el thmmbus, SEC or ~;Iht,to,lelt 
shunt oenlln~ced as al~repdate the empld~ de~slen made ~ to TEE, to 
anttco~gulate (65%; 1 l i t  7) or not to anticoagulate ('~ .%; 10lit 38) (p,- 0,004). 
Conc!us/ons: These data am consistent will1 a significant impact ot TEE 
on the clinical management ol patients with potential ambel¢ events. Future 
studies addressing the effectiveness of treatment, guided by TEE findings, in 
the prevention of recurrent embol~ evenle are needed. 
• Tlclopldlne Activity on Spontaneous 
E©hoaontrast: A 11ranseeophageai 
Echocardlographl© Study 
C P.aiati, O. Cacratta, F. Canata, S. llicoto, P. Rizzon. "S. Maugen" 
Foundation, Division of Car#,olo~, Cassano Murge: Institute of Cam~y.  
Universi(y of Caglmn and Ban, Italy 
Background: Spontaneous echocontrast (SEC) in the left atnum is deemed 
to be a risk factor for penpherel thmmboembolism Itis possible that platelet 
aggregation can play a role in the genesis of SEC. Therefore. the aim ol this 
study was to veery whether Tlclopidine (TIC), a powedul antiplatelet agent. 
could suppress or attenuate the SEC density in the left atoum. 
Methods: For this pulpose, a phase II clinical thai (two-siege descjn) was 
undertaken. In the first stage, 12 patients wflh non valvular atrial libnllation 
and stable SEC density in the left affium as assessed by transeeophageal 
echocardiography (TEE), received Tlclopidice, 500 rag/day, for 2 weeks. At 
the end of the 14-day treatment a further TEE study was performed. Before 
TIC treatment was initiated, the stability of SEC density was detenmined by 
repeating the TEE evaluation after 14 days from the first TEE screening study. 
In each patient !he gain seffing, optimized in the first study, was kept un- 
changed in the further 2 studies. SEC density was scored by the consensus of 
two expedenced observers, as being absent, mild, moderate or severe. The 
TEE-study rea, !ing was perforated in a blinded manner. 
Results: Tlctopidlne was well tolerated. Before TIC. SEC density was 
scored as being mild in 7 cases (58%), moderate in 1 case (8%) and severe in 
4 cases (33%). After TIC, the score remained unchanged, the response rate 
being zero. Therefore, Ticlopidine did not modify the SEC density in the left 
atdum at all in the first stage of the trial. For this reason, in accordance with 
the study design, the second stage was not undertaken. 
Conclusion: in this phase II clinical thai, antiplatelet treatment, using Ticlo- 
pidine 500 rag/day, was ineffective in abolishing or in reducing the SEC density 
in the left atnum. Platelet aggregation, therefore, does not seem to play a role 
in the genesis of spontaneous echocontrast. 
